23andMe Holding Co. (ME)
USD 3.14
(-3.09%)
USD 3.14
(-3.09%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 76.51 Million USD | -10.3% |
| 2022 | 85.3 Million USD | -1.16% |
| 2021 | 86.3 Million USD | -7.91% |
| 2020 | 93.72 Million USD | 3.76% |
| 2019 | 90.32 Million USD | -21.58% |
| 2018 | 115.18 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 74.16 Million USD | -3.07% |
| 2023 Q2 | 81.04 Million USD | -2.63% |
| 2023 Q1 | 83.23 Million USD | -2.43% |
| 2023 FY | 76.51 Million USD | -10.3% |
| 2023 Q3 | 78.82 Million USD | -2.75% |
| 2023 Q4 | 76.51 Million USD | -2.93% |
| 2022 Q1 | 84.12 Million USD | -2.52% |
| 2022 Q3 | 79.6 Million USD | -2.79% |
| 2022 Q4 | 85.3 Million USD | 7.17% |
| 2022 FY | 85.3 Million USD | -1.16% |
| 2022 Q2 | 81.88 Million USD | -2.67% |
| 2021 Q1 | 90.52 Million USD | -3.41% |
| 2021 FY | 86.3 Million USD | -7.91% |
| 2021 Q4 | 86.3 Million USD | -1.6% |
| 2021 Q3 | 87.7 Million USD | -1.11% |
| 2021 Q2 | 88.69 Million USD | -2.02% |
| 2020 Q4 | 93.72 Million USD | 5.3% |
| 2020 Q2 | - USD | 0.0% |
| 2020 FY | 93.72 Million USD | 3.76% |
| 2020 Q3 | 89 Million USD | 0.0% |
| 2020 Q1 | - USD | 0.0% |
| 2019 FY | 90.32 Million USD | -21.58% |
| 2018 FY | 115.18 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Bionano Genomics, Inc. | 87.94 Million USD | 12.999% |
| Prenetics Global Limited | 2.36 Million USD | -3129.315% |
| Star Equity Holdings, Inc. | 3.6 Million USD | -2020.116% |
| CareDx, Inc | 34.22 Million USD | -123.591% |
| Exact Sciences Corporation | 2.55 Billion USD | 97.005% |
| Exagen Inc. | 23.72 Million USD | -222.562% |
| Inotiv, Inc. | 417.64 Million USD | 81.679% |
| Guardant Health, Inc. | 1.35 Billion USD | 94.348% |
| Biodesix, Inc. | 60.69 Million USD | -26.073% |
| BioNexus Gene Lab Corp. | 133.39 Thousand USD | -57259.721% |
| Precipio, Inc. | 1.11 Million USD | -6756.183% |
| iSpecimen Inc. | 196.24 Thousand USD | -38889.727% |
| Natera, Inc. | 441.99 Million USD | 82.689% |
| Aspira Women's Health Inc. | 2.26 Million USD | -3276.655% |
| Standard BioTools Inc. | 98.21 Million USD | 22.09% |
| Castle Biosciences, Inc. | 15.31 Million USD | -399.771% |
| Personalis, Inc. | 48.96 Million USD | -56.274% |
| Aclaris Therapeutics, Inc. | 426 Thousand USD | -17861.268% |
| Applied DNA Sciences, Inc. | 1.23 Million USD | -6081.732% |
| OpGen, Inc. | 13.04 Million USD | -486.605% |
| T2 Biosystems, Inc. | 49.49 Million USD | -54.582% |
| Myriad Genetics, Inc. | 145 Million USD | 47.231% |
| ICON Public Limited Company | 3.93 Billion USD | 98.057% |
| NeoGenomics, Inc. | 611.67 Million USD | 87.491% |
| Star Equity Holdings, Inc. | 3.6 Million USD | -2020.116% |
| IDEXX Laboratories, Inc. | 947.88 Million USD | 91.928% |
| RadNet, Inc. | 1.49 Billion USD | 94.869% |
| MDxHealth SA | 41.26 Million USD | -85.423% |
| Psychemedics Corporation | 2.29 Million USD | -3229.634% |
| Illumina, Inc. | 2.26 Billion USD | 96.617% |
| Check-Cap Ltd. | - USD | -Infinity% |
| Twist Bioscience Corporation | 94.06 Million USD | 18.661% |
| DarioHealth Corp. | 29.54 Million USD | -159.013% |
| Fulgent Genetics, Inc. | 14.9 Million USD | -413.282% |
| Sera Prognostics, Inc. | 1.85 Million USD | -4018.138% |
| ENDRA Life Sciences Inc. | 394.4 Thousand USD | -19300.207% |
| OPKO Health, Inc. | 326.56 Million USD | 76.57% |
| Medpace Holdings, Inc. | 142.12 Million USD | 46.162% |
| Neogen Corporation | 906.23 Million USD | 91.557% |
| Intelligent Bio Solutions Inc. | 871.44 Thousand USD | -8680.295% |
| Prenetics Global Limited | 2.36 Million USD | -3129.315% |
| Mainz Biomed B.V. | 7.42 Million USD | -931.091% |
| bioAffinity Technologies, Inc. | 1.57 Million USD | -4746.897% |
| Trinity Biotech plc | 67.42 Million USD | -13.478% |
| Neuronetics, Inc. | 62.47 Million USD | -22.475% |
| Sotera Health Company | 2.32 Billion USD | 96.712% |
| bioAffinity Technologies, Inc. | 1.57 Million USD | -4746.897% |